![]() |
Jan Holgersson, MD, PhD"We are paving the way for the development of mucin-based biopharmaceuticals targeting the vaccine and anti-microbials markets." |
![]() |
Tomas Johansson, PhD“My primary objective is to establish the foundation for our purification strategies.” |
![]() |
Anki Gustafsson, PhD”My focus is on maximizing the full biomedical potential of carbohydrates.” |
![]() |
Lena Strindelius, PhD”Improving the uptake of antigens to increase the efficacy of vaccines is really challenging.” |